Acute angle-closure glaucoma is a sudden spike in eye pressure that can permanently damage your vision within hours if left untreated. In Europe, it affects roughly two to four people per 100,000 each year, but its real danger lies less in how common it is and more in how quickly it can steal sight and how often it gets mistaken for something else.1PubMed Central. Acute Closed-Angle Glaucoma-an Ophthalmological Emergency The condition demands same-day treatment by an eye specialist, and the difference between a good outcome and lasting vision loss often comes down to a few hours.
What Happens Inside the Eye
Your eye constantly produces a clear fluid called aqueous humor, which flows from behind the iris, through the pupil, and drains out through a mesh-like channel at the angle where the iris meets the cornea. In acute angle closure, that drainage angle gets physically blocked. Pressure inside the eye can jump from a normal range of around 10–21 mmHg to 40, 60, or even higher. At those levels, blood supply to the optic nerve is choked off and nerve fibers start dying.
The most common trigger is called pupillary block. When the iris presses tightly against the lens, fluid gets trapped behind the iris, bowing it forward and sealing off the drainage angle. This tends to happen in eyes that are already anatomically predisposed, meaning the angle is naturally narrow to begin with. But a second, less common mechanism can also cause an attack. Certain medications, especially sulfonamide-derived drugs like topiramate, can cause the ciliary body behind the iris to swell and push the entire lens-iris assembly forward, closing the angle from behind.2PubMed Central. Systemic Medications as Triggers of Acute Angle-Closure Glaucoma: A Narrative Review This second mechanism matters because it hits both eyes at once and doesn’t respond to the same first-line treatments.
Symptoms You Should Recognize
The textbook presentation is dramatic: sudden severe pain in or around one eye, blurred vision, halos around lights, a red eye, and a rock-hard feeling to the eyeball. But what makes acute glaucoma tricky is that many people don’t present with the full picture. Headache, nausea, and vomiting can dominate the symptom profile so completely that the eye complaint gets overlooked.1PubMed Central. Acute Closed-Angle Glaucoma-an Ophthalmological Emergency A severe headache with vomiting can look like a migraine, a stroke, or a gastrointestinal emergency, especially in an older person who may not volunteer that their vision has gone fuzzy.
Halos around lights deserve special mention. They happen because the swollen cornea scatters incoming light, and they are one of the most distinctive clues that this is an eye problem. If you experience sudden rainbow-colored halos along with eye pain or a headache, that combination should prompt an immediate trip to the emergency room, not a wait-and-see approach.
Why It Gets Misdiagnosed
One of the most sobering facts about acute glaucoma is how often the initial diagnosis is wrong. A study at one UK eye unit found that only about 40% of patients with acute angle closure were correctly diagnosed by the referring doctor. When the diagnosis was missed, treatment was delayed by an average of nearly six days.3Age and Ageing. Misdiagnosis of Acute Angle Closure Glaucoma General practitioners were the group most likely to miss it, while emergency department doctors fared better, likely because they more routinely check eye pressure.
A Korean emergency-room study echoed these findings. Patients who arrived complaining primarily of headache, nausea, or other non-eye symptoms were far more likely to experience a delayed diagnosis than those who walked in saying their eye hurt. Being initially seen by a non-ophthalmologist also significantly increased the odds of delay.4Journal of the Korean Ophthalmological Society. Clinical Features of Delayed Diagnosed Acute Angle Closure Glaucoma in an Emergency Room The practical takeaway is that if you have any new visual disturbance alongside a sudden severe headache, tell the triage staff explicitly about your eyes. Don’t let the headache or nausea be the only thing on the chart.
Who Is Most at Risk
The single biggest anatomical risk factor is a shallow anterior chamber, the space between the cornea and the iris. People whose anterior chambers are shallower than average have a narrower drainage angle, and the narrower that angle, the easier it is for the iris to seal it shut. In two large population studies comparing East Asian groups, the odds of having peripheral adhesions in the drainage angle climbed steeply as anterior chamber depth decreased. People with the shallowest measurements had between 16 and 174 times the risk compared to those with more spacious anatomy.5Archives of Ophthalmology. Anterior Chamber Depth and the Risk of Primary Angle Closure in 2 East Asian Populations
Several demographic patterns emerge from the literature. Women are affected more often than men, partly because female eyes tend to have shallower anterior chambers. The risk rises with age, as the lens grows thicker throughout life and gradually pushes the iris forward. East Asian and Inuit populations have higher rates of angle closure than populations of European descent. One reason is that people of East Asian ancestry tend to have smaller anterior chamber dimensions on average.6PubMed Central. Ethnic Difference of the Anterior Chamber Area and Volume and Its Association with Angle Width Hyperopia, or farsightedness, is another well-known risk factor because farsighted eyes are typically shorter from front to back, which crowds the front chamber.
An Evolutionary Footnote on Shallow Anterior Chambers
A fascinating hypothesis suggests that shallow anterior chambers may not be a design flaw at all but a cold-weather adaptation. The idea, first proposed in the 1970s based on observations of Greenlandic Inuit, is that a shallower space behind the cornea could help insulate the eye against extreme cold. With the iris sitting closer to the cornea, the warm aqueous humor would heat the cornea more effectively, potentially reducing the risk of corneal freezing. More recent population-genetic data on human migration routes through northeast Asia during the last Ice Age have kept this hypothesis alive, though it remains speculative.7PubMed. Anterior chamber depth and primary angle-closure glaucoma: an evolutionary perspective If correct, it would mean that the very anatomy that protected early humans from frostbite now predisposes their descendants to glaucoma.
Medications That Can Trigger an Attack
A wide range of commonly prescribed medications can push a susceptible eye into acute angle closure. The drugs fall roughly into two categories based on how they do it. The first group causes the pupil to dilate, which bunches the iris tissue at its base and blocks the drainage angle. This is the pupillary-block mechanism, and it is triggered by drugs with anticholinergic, adrenergic, or serotonergic effects.8PubMed Central. Drug-induced Acute Angle-closure Glaucoma: A Review
The list of offenders is long and includes some very common drugs:
- Antidepressants: SSRIs, SNRIs, tricyclics, and MAO inhibitors can all influence pupil size through serotonergic or anticholinergic pathways.
- Antipsychotics: Both older (typical) and newer (atypical) antipsychotics carry some risk through anticholinergic and dopaminergic mechanisms.
- Over-the-counter decongestants: Adrenergic nasal sprays and oral decongestants dilate the pupil and can provoke an attack in someone with narrow angles.
These drugs typically trigger a one-sided attack in a person whose eye anatomy was already borderline.9PubMed. Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management
The second category works differently. Sulfonamide derivatives, especially topiramate (used for migraines and seizures), can cause swelling of the ciliary body and choroidal tissue behind the iris. This pushes the lens and iris forward, closing the angle without any pupil dilation at all.10PubMed. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma The hallmark of topiramate-induced angle closure is that it hits both eyes simultaneously and causes a sudden shift toward nearsightedness. Ultrasound imaging in affected patients consistently shows swelling behind the iris pushing everything forward.11PubMed Central. Topiramate-induced acute bilateral angle closure glaucoma confirmed by ultrasound biomicroscopy The treatment is to stop the drug, not to perform laser iridotomy, because the problem is not a pupillary block.
Emergency Treatment
The immediate goal is to bring the eye pressure down as fast as possible. In the emergency room or eye clinic, this usually involves a combination of eye drops and systemic drugs given at the same time. Topical medications include drugs that constrict the pupil (like pilocarpine), beta-blockers, and alpha-agonists, all aimed at either opening the drainage angle or reducing fluid production. Oral or intravenous carbonic anhydrase inhibitors and, in severe cases, intravenous mannitol, are used to pull fluid out of the eye more aggressively.12PubMed Central. Emergency management: angle-closure glaucoma
The critical point, backed by outcome data, is speed. The longer the gap between the start of symptoms and effective pressure reduction, the worse the visual outcome. One study found that when symptoms lasted longer than seven days before treatment, the risk of significant visual field loss rose sharply.13PubMed. The visual field following acute primary angle closure The recommended standard is that you should be seen by an ophthalmologist the same day symptoms begin.1PubMed Central. Acute Closed-Angle Glaucoma-an Ophthalmological Emergency
Laser Iridotomy and What Comes After
Once the acute pressure spike has been controlled with medications, the definitive treatment for most cases of pupillary-block angle closure is laser peripheral iridotomy. The ophthalmologist uses a laser to create a tiny hole in the outer edge of the iris, giving the trapped fluid behind it a shortcut into the front chamber. This equalizes pressure across the iris, allowing it to fall back from the drainage angle.
Iridotomy works well at widening the drainage angle across the full spectrum of angle-closure disease. However, its success at fully resolving the problem varies considerably. An American Academy of Ophthalmology review found that after iridotomy, some degree of persistent angle closure was reported in anywhere from 2% to 57% of eyes, depending on the severity of disease and the study. The people most likely to have residual problems were those with thicker irises, a more forward-positioned ciliary body, or greater lens vault, features suggesting that something beyond simple pupillary block was contributing to the angle closure.14PubMed. Laser Peripheral Iridotomy in Primary Angle Closure Among patients who had experienced an acute attack specifically, between roughly one-fifth and one-half needed additional pressure-lowering treatment after iridotomy.
For patients who need more than iridotomy, early lens extraction through cataract-style surgery is emerging as an alternative. A Cochrane systematic review comparing lens removal to iridotomy in acute angle closure found that lens extraction resulted in better pressure control at 18 to 24 months and substantially reduced the need for further surgery. The certainty of the evidence is still low, but the direction of the findings was consistent.15PubMed Central. Lens extraction versus laser peripheral iridotomy for acute primary angle closure Removing the natural lens and replacing it with a thin artificial one dramatically deepens the anterior chamber, essentially eliminating the anatomical crowding that caused the problem. For older patients who already have some cataract formation, this approach solves two problems at once.
Protecting the Other Eye
If you have an acute attack in one eye, the other eye is almost certainly at risk. Both eyes share the same anatomy, and the fellow eye’s narrow angle makes a future attack probable rather than possible. Surveys of glaucoma specialists have long held that preventive laser iridotomy should be performed on the unaffected eye as soon as practical.16PubMed. Treatment of the fellow eye in acute angle-closure glaucoma: a case report and survey of members of the American Glaucoma Society A study tracking 80 fellow eyes that received prophylactic iridotomy found that none of them went on to develop an acute attack, while in the same cohort one patient’s fellow eye had an attack before iridotomy could be performed.17PubMed. Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy The evidence strongly supports treating the other eye without waiting.
Long-Term Visual Outcomes
Even after successful treatment, not everyone walks away with perfect vision. About 38% of patients still had measurable visual field defects six months after an acute episode in one study, with most of the damage following the pattern of nerve-fiber loss typical of glaucoma.13PubMed. The visual field following acute primary angle closure The people most likely to have lasting damage were those who had pre-existing chronic glaucoma underneath the acute event, those who developed elevated pressure during follow-up, and those whose symptoms had gone on for more than a week before treatment.
A more recent study drilling into which baseline factors predicted long-term visual field loss found three standouts: a longer delay between symptom onset and pressure lowering, a higher pressure at the time of presentation, and a specific iris shape (flat iris curvature) on imaging. In combination, those three factors were highly accurate at predicting who would end up with visual field loss.18PubMed. Predictors of long-term visual field outcome after an episode of acute primary angle closure The consistent message is that the modifiable factor with the biggest impact on your outcome is how fast you get treated. The anatomy you walked in with and the pressure at presentation are largely out of your control, but delay is not.
Quality of life takes a hit even for patients whose visual fields technically survive intact. Research on people with angle-closure glaucoma found that vision-related quality of life was lower across nearly every domain tested compared to healthy controls, and the drop was steepest for those with documented visual field loss. Areas like mental health, ability to perform near tasks, and sense of independence were all affected.19PubMed Central. Vision-Related Quality of Life in Primary Angle-Closure Glaucoma Patients with or without Visual Field Dysfunction
When It Happens in Younger People
Acute glaucoma is overwhelmingly a condition of middle-aged and older adults, but it does occasionally show up in younger people. When it does, the underlying cause is usually quite different. In older patients, the culprit is almost always the gradual thickening of the lens with age in an eye that was already crowded. In younger patients, angle closure tends to stem from structural or developmental eye abnormalities.
A study of angle-closure patients under 40 found that plateau iris syndrome was the most common diagnosis, followed by iridociliary cysts, complications of retinopathy of prematurity, and inflammatory eye disease. Standard pupillary-block mechanisms were uncommon.20PubMed. Angle closure in younger patients A separate 15-year review from a single center found that primary angle-closure glaucoma mainly showed up after age 30, while anterior segment developmental abnormalities were the top cause of angle closure in patients under 20.21PubMed Central. Etiologies and clinical characteristics of young patients with angle-closure glaucoma: a 15-year single-center retrospective study For young patients or their parents, the key point is that angle closure at an early age warrants a more thorough workup than in older adults, because the list of possible causes is broader and includes conditions that may need different treatment.
Imaging and Diagnosis Beyond the Slit Lamp
The gold-standard way to assess the drainage angle has traditionally been gonioscopy, where the ophthalmologist places a special lens on your eye to directly view the angle. It requires skill and cooperation from the patient, and results can vary between examiners. Anterior segment optical coherence tomography, a non-contact imaging technique, has been studied as a potential alternative or supplement. A meta-analysis of 23 studies found that its sensitivity for detecting angle closure ranged widely but hit a median of 87%, with specificity around 84%.22PubMed Central. Diagnostic accuracy of AS-OCT vs gonioscopy for detecting angle closure: a systematic review and meta-analysis The technology is improving and offers the advantage of being quick, painless, and reproducible, which is particularly useful for screening people who might be at risk but have not yet had an attack.